Navigation Links
MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
Date:6/29/2009

utive RSV seasons and begin patient enrollment in fall 2009, with a target of 3,000 participants across 100 outpatient sites in the United States. The study population will include infants born 32-to-35 weeks (GA) who do not receive RSV prophylaxis during their first RSV season.

About RSV

Each year, up to 125,000 infants in the United States are hospitalized with severe RSV infections, the leading cause of lower respiratory tract infections in U.S. infants. RSV is the most common respiratory infection in infancy or childhood. Approximately one-half of all infants are infected with RSV during the first year of life, and nearly all children have been infected at least once by the time they reach their second birthday. Children born prematurely as well as those with chronic lung disease (CLD) or congenital heart disease (CHD) are at highest risk for severe disease and hospitalization due to RSV. The virus may also cause severe illness in other high-risk groups.

A recent study published in the New England Journal of Medicine found that RSV accounts for one of every 13 visits to a pediatrician, one of every 38 emergency room trips, and inpatient hospital stays for one out of every 334 children.

About MedImmune

MedImmune, the worldwide biologics business for AstraZeneca PLC (LSE: AZN.L, NYSE: AZN), has approximately 3,100 employees worldwide and is headquartered in Gaithersburg, Maryland. With an advancing pipeline of promising candidates, we aim to be the next revolutionary force in biotechnology by delivering life-changing products, industry-leading performance, and a tireless commitment to improving patient health. For more information, visit MedImmune's website at www.medimmune.com.


'/>"/>
SOURCE MedImmune
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
2. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
3. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
4. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
5. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
6. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
7. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
8. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
9. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
10. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
11. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... -- Obsidian HDS, the developer of PharmaShine ( www.pharmashine.com ... of data on pharmaceutical and device industry payments to ... 2014 Open Payments General and Research data released by ... data disclosed on Open Payments for 2014 includes information ... $6.49 billion and is the largest public disclosure of ...
(Date:7/2/2015)... VANCOUVER , July 2, 2015 /PRNewswire/ - ESSA Pharma ... its common shares have been approved for listing and trading ... ESSA will begin trading on NASDAQ on July ... TSX Venture Exchange under the symbol "EPI". As ... the NASDAQ, each of the Company,s outstanding special warrants issued ...
(Date:7/2/2015)... OXFORD, England , July 2, 2015 ... commonly known as ,Friendly Aedes aegypti , ... of Juazeiro, Brazil by 95%, ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The ... of a trial of Oxitec,s genetically engineered mosquitoes. The ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
... Sept. 18 Worldwide markets of,approved EGFr/HEr2 inhibitors grew ... to more than $3.2 billion, exceeding total sales reported ... expanding,indications for these drugs and fueling continued rapid market ... than 50 novel,agents targeting this pathway are in development. ...
... FOLD ) today announced that it plans to ... HCl) for Pompe Disease at the,American Society of Human ... CA. This plan was announced by John Crowley, President ... & Medtech 2007 Conference in London, United Kingdom. ...
Cached Medicine Technology:Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease 2
(Date:7/3/2015)... TX (PRWEB) , ... July 03, 2015 , ... ... the United States, named Mariah N. Manzanares, MD as the new Medical Director of ... new facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive ...
(Date:7/2/2015)... VA (PRWEB) , ... July 02, 2015 , ... sweetFrog ... Albany, Mississippi. The opening is the first sweetFrog store located in Mississippi. The premium ... growing companies in 2014. , The store, located at 104 Railroad Avenue, New Albany, ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking Consultants specified ... of Minnesota, they knew it would save the university energy and maintenance costs. ... the total energy savings after installation was an impressive 89 percent, which resulted ...
(Date:7/2/2015)... ... ... As Americans celebrate the Fourth of July outdoors this weekend, local physicians ... July is UV Safety Month, and physicians at American Family Care and AFC Doctors ... Experts say most skin cancers can be found early with regular skin exams. Physicians ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ActiveBunch.com recently ... passion for social fitness. Built to function as a lifestyle community, Active Bunch allows ... the opportunity to network, meet, and participate in discussions or group events. , ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2
... to Create a Sustainable Model for ... ... ZMH ; SWX: ZMH) today announced comprehensive changes in its,corporate compliance ... support the development and marketing,of products and services that address unmet clinical ...
... 17 Family Research Council,Action applauds GOP Presidential ... from Villanova University supporting the pro-life,platform of the ... record of possible running mates., FRC Action,s ... to hear Senator McCain depict his support for ...
... The U.S. Agency for,International Development and Iraq,s ... Understanding (MOU) outlining a shared vision and,collaborative effort ... to,deliver health services to Iraqi citizens, and contribute ... MOU strengthens the strategic cooperation between the MoH ...
... Medical,Innovations, Inc. (Amex: IMA ), a global ... it will release its first quarter,2008 earnings on ... host a,conference call beginning at 10:00 a.m. (Eastern ... other corporate matters. During the conference,call the Company ...
... 17 LabX.com, the first,business-to-business internet auction ... it has acquired the print and digital,publication ... Amherst ,NH . Vicon Publishing will continue ... Magazine, Controlled Environments Magazine(R), and,Forensic Magazine(R). Lab ...
... HVAC company provides tips for improving indoor air quality, ... National,Indoor Comfort Week, Atlas Butler Heating and Cooling is ... in their homes and offices,is free of harmful pollutants., ... indoor,environmental systems on which everyone relies, and honors the ...
Cached Medicine News:Health News:Zimmer Announces New Compliance Model 2Health News:Zimmer Announces New Compliance Model 3Health News:Zimmer Announces New Compliance Model 4Health News:Zimmer Announces New Compliance Model 5Health News:Zimmer Announces New Compliance Model 6Health News:Zimmer Announces New Compliance Model 7Health News:FRC Action Praises John McCain's Pro-Life Comments 2Health News:Iraq's Ministry of Health and USAID Sign Memorandum of Understanding to Increase Cooperation in Public Management 2Health News:Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results 2Health News:Internet Auction Site LabX Acquires Lab Manager Magazine(R) Print and Digital Publications, E-Newsletters, Website and Conference 2Health News:National Indoor Comfort Week - A Breath of Fresh Air for Allergy Sufferers 2
Available in 10 beautiful opaque colors....
A new generation of enhancing color contact lens designed specifically for light eyes....
Expressions Accents contact lenses let you enhance your eyes natural color while enjoying incredible comfort and outstanding vision quality....
... the appearance of photo-aged skin, removes age ... telangiectasias, and broken capillaries. This innovative new ... pigmentary sun damage through a process called ... and the Nd:YAG Laser is optimized for ...
Medicine Products: